These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 4165949)

  • 1. Immunoelectrophoretic investigations of the serum of carriers of Duchenne's progressive muscular dystrophy.
    Askanas W
    Life Sci; 1966 Oct; 5(19):1775-80. PubMed ID: 4165949
    [No Abstract]   [Full Text] [Related]  

  • 2. Identification of the agent responsible for the abnormal immunoelectrophoretic pattern of serum in Duchenne's progressive muscular dystrophy.
    Askanas W
    Life Sci; 1966 Oct; 5(19):1767-73. PubMed ID: 4165948
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immunoelectrophoretic serum studies of patients with progressive muscular dystrophy of Duchenne's type].
    Askanas W
    Neurol Neurochir Pol; 1967; 1(2):141-6. PubMed ID: 4168421
    [No Abstract]   [Full Text] [Related]  

  • 4. [Paper- and immunoelectrophoretic as well as nephelometric studies on serum proteins in patients with progressive muscular dystrophy].
    Mühlbach R; Wegner G; Hofer F
    Beitr Orthop Traumatol; 1975 Jan; 22(1):56-7. PubMed ID: 804898
    [No Abstract]   [Full Text] [Related]  

  • 5. Serum cytoplasmic and mitochondrial aspartate aminotransferase in Duchenne's progressive muscular dystrophy.
    Janik P; Nowak I; Niebrój-Dobosz I
    Mater Med Pol; 1994; 26(3):101-4. PubMed ID: 7603078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunoelectrophoretic studies in patients with progressive muscular dystrophy].
    Mühlbach R
    Z Gesamte Inn Med; 1969 May; 24(10):156-8. PubMed ID: 5807428
    [No Abstract]   [Full Text] [Related]  

  • 7. [Immunoelectrophoretic studies in patients with progressive muscular dystrophy].
    Mühlbach R
    Z Gesamte Inn Med; 1969 Jan; 24(1):Suppl:156-8. PubMed ID: 5402575
    [No Abstract]   [Full Text] [Related]  

  • 8. Mosaic expression of dystrophin in symptomatic carriers of Duchenne's muscular dystrophy.
    Arahata K; Ishihara T; Kamakura K; Tsukahara T; Ishiura S; Baba C; Matsumoto T; Nonaka I; Sugita H
    N Engl J Med; 1989 Jan; 320(3):138-42. PubMed ID: 2643040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Characteristics of the phospholipid composition of erythrocyte membranes in Duchenne's progressive muscular dystrophy].
    Badalian LO; Temin PA; Griniu LP; Islamova IB; Tananova GV
    Pediatriia; 1984 Oct; (10):28-30. PubMed ID: 6514459
    [No Abstract]   [Full Text] [Related]  

  • 10. [Influence of ouabain on the electrophoretic mobility of erythrocytes in 7 patients with Duchenne's muscular dystrophy].
    Szibor R; Redmann K; Keike H; Müller K
    Helv Paediatr Acta; 1976 Oct; 31(3):249-56. PubMed ID: 977375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Duchenne's muscular dystrophy in six siblings. The case for early diagnosis and neonatal screening.
    Moosa A
    S Afr Med J; 1982 Nov; 62(21):765-7. PubMed ID: 7135141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Discriminant analysis of methods for detecting the heterozygote carrier state for the Duchenne muscular dystrophy gene].
    Khrennikov VIu; Sitnikov VF; Deev AI; Svintsitskiĭ IV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(11):14-8. PubMed ID: 3223151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Duchenne's muscular dystrophy: studies in cultured fibroblasts.
    Wyatt PR; Cox DM
    Lancet; 1977 Jan; 1(8004):172-4. PubMed ID: 64702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Composition of erythrocyte phospholipids in Duchenne's muscular dystrophy].
    Beyer P; Bieth R; Robert J; Freysz H; Uhl T
    Ann Pediatr (Paris); 1980 Apr; 27(4):233-6. PubMed ID: 7224543
    [No Abstract]   [Full Text] [Related]  

  • 15. Leber's congenital amaurosis with Duchenne's muscular dystrophy.
    Hazariwala K; Brownstein S; Polomeno R; Little JM; Labuda D
    Can J Ophthalmol; 1990 Jun; 25(4):202-7. PubMed ID: 1972344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rhabdomyolysis in association with Duchenne's muscular dystrophy.
    Obata R; Yasumi Y; Suzuki A; Nakajima Y; Sato S
    Can J Anaesth; 1999 Jun; 46(6):564-6. PubMed ID: 10391604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevations of hemopexin levels in neuromuscular disease.
    Adornato BT; Engel WK; Foidart-Desalle M
    Arch Neurol; 1978 Sep; 35(9):577-80. PubMed ID: 99125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastric hypomotility in Duchenne's muscular dystrophy.
    Barohn RJ; Levine EJ; Olson JO; Mendell JR
    N Engl J Med; 1988 Jul; 319(1):15-8. PubMed ID: 3380114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prenatal diagnosis and detection of carriers with DNA probes in Duchenne's muscular dystrophy.
    Darras BT; Harper JF; Francke U
    N Engl J Med; 1987 Apr; 316(16):985-92. PubMed ID: 3561454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of dystrophin expression after activation of myogenesis in amniocytes, chorionic-villus cells, and fibroblasts. A new method for diagnosing Duchenne's muscular dystrophy.
    Sancho S; Mongini T; Tanji K; Tapscott SJ; Walker WF; Weintraub H; Miller AD; Miranda AF
    N Engl J Med; 1993 Sep; 329(13):915-20. PubMed ID: 8361505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.